BKYI
BIO-key International, Inc.
BKYI offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT
Caterpillar Inc.
CAT has the edge over BKYI overall, supported by stronger fundamentals and lower modeled downside.
BKYI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
BKYI's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
BKYI PE Valuation
BKYI has no meaningful PE right now: it lost money over the past year.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
BKYI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BKYI's losses to shrink, with revenue growing.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
BKYI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$7.93 | +$3.37 |
| Q1 2026 | -$9.37 | +$9.93 |
| Q4 2025 | -$10.77 | +$10.13 |
| Q3 2025 | -$8.90 | +$53.20 |
| Q2 2025 | -$11.30 | +$59.50 |
| Q1 2025 | -$19.30 | +$70.30 |
| Q4 2024 | -$20.90 | +$70.90 |
| Q3 2024 | -$62.10 | +$135.55 |
BKYI lost $7.93 per share over the past year, a smaller loss than the year before.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over BKYI on earnings quality, reporting a profit while its opponent remains loss making.
BKYI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.9M | +13% |
| Q1 2026 | $2.1M | +33% |
| Q4 2025 | $1.1M | -26% |
| Q3 2025 | $1.5M | -28% |
| Q2 2025 | $1.7M | +49% |
| Q1 2025 | $1.6M | -26% |
| Q4 2024 | $1.5M | -20% |
| Q3 2024 | $2.1M | +18% |
BKYI's revenue is recovering but still below its 2023 peak: $2M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -28% | +36 points |
| Q1 2026 | -7.3% | +33 points |
| Q4 2025 | -389% | -302 points |
| Q3 2025 | -58% | -31 points |
| Q2 2025 | -64% | +81 points |
| Q1 2025 | -40% | -17 points |
| Q4 2024 | -87% | +63 points |
| Q3 2024 | -27% | +15 points |
BKYI's operating margin was −28% last quarter, up 36 points from the same quarter a year ago.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over BKYI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over BKYI on profitability, with a higher operating margin.
BKYI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$845.7K | +$35.7K |
| Q1 2026 | -$358K | +$481.9K |
| Q4 2025 | -$1.8M | -$1.3M |
| Q3 2025 | -$1.1M | +$173.1K |
| Q1 2025 | -$839.9K | -383% |
| Q4 2024 | -$504.6K | +$1M |
| Q3 2024 | -$1.3M | -$1.1M |
| Q1 2024 | $297.1K | +$2.2M |
BKYI has burned cash in almost every quarter: −$4M over the past year, against −$4M the year before.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over BKYI on cash generation, producing positive trailing cash flow while its opponent burns cash.
BKYI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +2K shares |
| 1 year | +121% | +567K shares |
| 3 years | +2191% | +992K shares |
| 5 years | +7058% | +1M shares |
BKYI has 1M diluted shares, up 121% from a year ago.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over BKYI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
BKYI Net Leverage
BKYI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
BKYI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.9 | Neutral |
| Stochastic | 29.9 | Neutral |
BKYI's weekly RSI is 42 (neutral) and its Stochastic is 30 (neutral).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BKYI PE vs Industrials Sector
BKYI has no meaningful PE right now: it lost money over the past year.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
BKYI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.41 | 7.1% above |
| 20 week MA | $3.16 | 18% below |
| 50 week MA | $4.70 | 45% below |
| 100 week MA | $7.00 | 63% below |
| 200 week MA | $33.8 | 92% below |
BKYI has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 92% below its 200-week average.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over BKYI on trend strength, trading above more of its moving averages.
BKYI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $705.9 | $624.6 | -12% |
| 2021 | $624.6 | $417.6 | -33% |
| 2022 | $417.6 | $108.1 | -74% |
| 2023 | $108.1 | $30.0 | -72% |
| 2024 | $30.0 | $14.1 | -53% |
| 2025 | $14.1 | $6.06 | -57% |
| 2026 YTD | $6.06 | $2.58 | -57% |
BKYI has finished every year since 2020 lower, and it's down 57% so far in 2026.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over BKYI on returns for 2026, with the stronger performance.